Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Sato

Showing results (281-290 of 425) with videos related to

Pageof 43
Sort By:
Medical Molecular Morphology|September 20, 2020
Aberrant expression of DUSP4 is a specific phenomenon in betel quid-related oral cancerBhoj Raj Adhikari, Koki Yoshida, Durga Paudel, et al.
Molecular and Cellular Endocrinology|August 8, 2014
Induction of adrenomedullin 2/intermedin expression by thyroid stimulating hormone in thyroidShuji Nagasaki, Motoko Fukui, Satoko Asano, et al.
BMC Cancer|August 10, 2012
Prognostic impact of detecting viable circulating tumour cells in gastric cancer patients using a telomerase-specific viral agent: a prospective studyHiroaki Ito, Haruhiro Inoue, Norimasa Sando, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|December 22, 2005
[An adult case of asymptomatic congenital tracheal stenosis]Koushi Yokomura, Kingo Chida, Takafumi Suda, et al.
Cancer Chemotherapy and Pharmacology|March 31, 2024
Correction to: Phase I study of the anti‑TIGIT antibody tiragolumab in combination with atezolizumab in Japanese patients with advanced or metastatic solid tumorsNoboru Yamamoto, Takafumi Koyama, Jun Sato, et al.
Cancer Chemotherapy and Pharmacology|January 11, 2024
Phase I study of the anti-TIGIT antibody tiragolumab in combination with atezolizumab in Japanese patients with advanced or metastatic solid tumorsNoboru Yamamoto, Takafumi Koyama, Jun Sato, et al.
Investigational New Drugs|April 11, 2022
Practical consideration for successful sequential tumor biopsies in first-in-human trialsTakafumi Koyama, Toshio Shimizu, Jun Sato, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 6, 2023
[Usefulness of an Epidural Catheter with a Subcutaneous Port for Locally Advanced Rectal Cancer Pain Which Was Difficult to Manage with Opioids-A Case Report]Akiharu Kimura, Akiko Morishita, Tomoaki Takase, et al.
ACS Infectious Diseases|November 5, 2020
Introduction of a Thio Functional Group to Diazabicyclooctane: An Effective Modification to Potentiate the Activity of β-Lactams against Gram-Negative Bacteria Producing Class A, C, and D Serine β-LactamasesMotohiro Fujiu, Katsuki Yokoo, Jun Sato, et al.
Asian Spine Journal|June 23, 2015
The Time Course Changes in Bone Metabolic Markers after Administering the Anti-Receptor Activator of Nuclear Factor-Kappa B Ligand Antibody and Drug Compliance among Patients with OsteoporosisKazuhide Inage, Sumihisa Orita, Kazuyo Yamauchi, et al.
Pageof 43

Showing results (281-290 of 425) with videos related to

Sort By:
Pageof 43
Medical Molecular Morphology|September 20, 2020
Aberrant expression of DUSP4 is a specific phenomenon in betel quid-related oral cancerBhoj Raj Adhikari, Koki Yoshida, Durga Paudel, et al.
Molecular and Cellular Endocrinology|August 8, 2014
Induction of adrenomedullin 2/intermedin expression by thyroid stimulating hormone in thyroidShuji Nagasaki, Motoko Fukui, Satoko Asano, et al.
BMC Cancer|August 10, 2012
Prognostic impact of detecting viable circulating tumour cells in gastric cancer patients using a telomerase-specific viral agent: a prospective studyHiroaki Ito, Haruhiro Inoue, Norimasa Sando, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|December 22, 2005
[An adult case of asymptomatic congenital tracheal stenosis]Koushi Yokomura, Kingo Chida, Takafumi Suda, et al.
Cancer Chemotherapy and Pharmacology|March 31, 2024
Correction to: Phase I study of the anti‑TIGIT antibody tiragolumab in combination with atezolizumab in Japanese patients with advanced or metastatic solid tumorsNoboru Yamamoto, Takafumi Koyama, Jun Sato, et al.
Cancer Chemotherapy and Pharmacology|January 11, 2024
Phase I study of the anti-TIGIT antibody tiragolumab in combination with atezolizumab in Japanese patients with advanced or metastatic solid tumorsNoboru Yamamoto, Takafumi Koyama, Jun Sato, et al.
Investigational New Drugs|April 11, 2022
Practical consideration for successful sequential tumor biopsies in first-in-human trialsTakafumi Koyama, Toshio Shimizu, Jun Sato, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 6, 2023
[Usefulness of an Epidural Catheter with a Subcutaneous Port for Locally Advanced Rectal Cancer Pain Which Was Difficult to Manage with Opioids-A Case Report]Akiharu Kimura, Akiko Morishita, Tomoaki Takase, et al.
ACS Infectious Diseases|November 5, 2020
Introduction of a Thio Functional Group to Diazabicyclooctane: An Effective Modification to Potentiate the Activity of β-Lactams against Gram-Negative Bacteria Producing Class A, C, and D Serine β-LactamasesMotohiro Fujiu, Katsuki Yokoo, Jun Sato, et al.
Asian Spine Journal|June 23, 2015
The Time Course Changes in Bone Metabolic Markers after Administering the Anti-Receptor Activator of Nuclear Factor-Kappa B Ligand Antibody and Drug Compliance among Patients with OsteoporosisKazuhide Inage, Sumihisa Orita, Kazuyo Yamauchi, et al.
Pageof 43